Related Experiment Videos
Osteoarthritis - an untreatable disease?
Heike A Wieland1, Martin Michaelis, Bernhard J Kirschbaum
1Therapeutic Department Thrombosis & Osteoarthritis, Aventis Pharma Deutschland GmbH, a company of the Sanofi-Aventis group, Industrial Park Höchst, 65926 Frankfurt, Germany. Heike.Wieland@sanofi-aventis.com
Nature Reviews. Drug Discovery
|April 2, 2005
Summary
Osteoarthritis is a complex joint disease with unknown causes, often diagnosed late. Emerging treatments offer new hope for managing this painful condition.
Area of Science:
- Rheumatology and Orthopedics
- Molecular Biology and Biochemistry
Background:
- Osteoarthritis (OA) is a prevalent, disabling joint disease affecting millions.
- Its multifactorial etiology remains largely unknown, complicating early diagnosis and treatment.
- Current diagnostic timelines lag behind disease onset, with advanced structural damage by the time symptoms appear.
Purpose of the Study:
- To review osteoarthritis as a whole-joint disease.
- To explore potential pathophysiological mechanisms, including lipid homeostasis dysregulation.
- To discuss emerging pharmacotherapeutic options for OA management.
Main Methods:
- Literature review of osteoarthritis pathophysiology and treatment.
- Analysis of current understanding of disease mechanisms.
- Evaluation of emerging therapeutic strategies.
Main Results:
- Osteoarthritis involves multiple pathophysiological mechanisms, with lipid homeostasis dysregulation as a key factor.
- No definitive disease-modifying therapies currently exist for osteoarthritis.
- Existing treatments for chronic osteoarthritic pain are inadequate.
Conclusions:
- Osteoarthritis is a complex disease of the entire joint, not just cartilage.
- Dysregulation of lipid homeostasis presents a potential therapeutic target.
- New pharmacotherapeutic options are under development for osteoarthritis.